Dr. Christina Manyama HoU: Clinical Research

{tab title="Qualifications" class="solid"}

• Msc. Clinical Trials at London School of Hygiene and Tropical Medicine (LSHTM) year 2017
• MD at Hubert Kairuki Memorial University (HKMU) year 2009

{tab title="Interests" class="green"}

Clinical trials in both TB and HIV fields, TB and TB drugs developments, Emerging diseases, Vaccine development

{tab title="Grants" class="blue"}

{tab title="Publications" class="blue"}

• Mangu C.D, Manyama C.K, Rumisha S.F, Sudi L, Kimera S.I and Mboera L.E.G (2016). Towards Developing an Early Warning System. Policy Brief NIMR/EPB/0082016
• Mangu C.D, Manyama C.K, Sudi L, Sabi I, Msila H, Nyanda E, Chaula G, Maboko L. Emerging viral infectious disease threat: Why Tanzania is not a safe zone. Tanzan J Health Res. 2016;18 (3): 1-14
• Mangu C.D, Manyama C.K, Msila H and Mboera L(2016) Policy Brief: Not all febrile case is Malaria Cases. National Institute for Medical research NIMR/EPB/002/2016
• Boeree MJ¹, Heinrich N², Aarnoutse R³, Diacon AH⁴, Dawson R⁵, Rehal S⁶, Kibiki GS⁷, Churchyard G⁸, Sanne I⁹, Ntinginya NE¹⁰, Minja LT¹¹, Hunt RD¹², Charalambous S¹³, Hanekom M⁴, Semvua HH⁷, Mpagama SG¹⁴, Manyama C¹⁰, Mtafya B¹⁰, Reither K¹⁵, Wallis RS¹³, Venter A¹⁶, Narunsky K⁵, Mekota A¹⁷, Henne S¹⁷, Colbers A³, van Balen GP¹⁸, Gillespie SH¹⁹, Phillips PPJ⁶, Hoelscher M²; PanACEA consortium (2017): High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. https://www.ncbi.nlm.nih.gov/pubmed/28100438#
• Reither K, Manyama C, Clowes P, Rachow A, Mapamba D, Steiner A, Ross A, Mfinanga E, Sasamalo M, Nsubuga M, Aloi F, Cirillo D, Jugheli L, Lwilla F. (2015): Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation. https://www.ncbi.nlm.nih.gov/pubmed/25312863#

{tab title="Current Projects" class="green"}

TB sequel, NC005 , Ncoo8 and NC005

{tab title="Contacts" class="solid"}

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

{/tabs}